AMGEN 16/26AMGEN 16/26AMGEN 16/26

AMGEN 16/26

No trades
See on Supercharts

Key terms


Outstanding amount
‪750.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
2.00% (Fixed)
Coupon frequency
Annual
Yield to maturity
2.79%
Maturity date
Feb 25, 2026
Term to maturity
1 year

About AMGEN 16/26


Sector
Health Technology
Industry
Biotechnology
Home page
Issue date
Feb 25, 2016
ISIN
XS1369278764
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.